Melqart Asset Management (Uk) LTD Cytokinetics Inc Transaction History
Melqart Asset Management (Uk) LTD
- $741 Million
- Q1 2025
A detailed history of Melqart Asset Management (Uk) LTD transactions in Cytokinetics Inc stock. As of the latest transaction made, Melqart Asset Management (Uk) LTD holds 999,447 shares of CYTK stock, worth $36.2 Million. This represents 5.42% of its overall portfolio holdings.
Number of Shares
999,447
Previous 1,136,434
12.05%
Holding current value
$36.2 Million
Previous $53.5 Million
24.86%
% of portfolio
5.42%
Previous 7.05%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
399Shares Held
128MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$531 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$429 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$360 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$289 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$220 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.41B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...